ESOPJul 17, 2026, 04:16 PM
Zenas BioPharma Grants 35,750 Stock Options, 79,050 RSUs to New Hires
AI Summary
Zenas BioPharma announced that its Compensation Committee granted 35,750 non-qualified stock options and 79,050 restricted stock units (RSUs) to newly hired employees on July 15, 2026. These grants serve as an inducement for employment, in accordance with Nasdaq Listing Rule 5635(c)(4). The stock options have an exercise price of $29.41 and vest over four years, as do the RSUs.
Key Highlights
- Granted 35,750 non-qualified stock options to new employees.
- Granted 79,050 restricted stock units (RSUs) to new employees.
- Stock options exercise price set at $29.41 per share.
- Stock options vest over a four-year period.
- RSUs vest in four equal installments over a four-year period.
- Grants are an inducement for new employees' entry into employment.
Price Impact
More from ZBIO